Karen Noblett - 18 Mar 2022 Form 4 Insider Report for Axonics, Inc.

Role
Chief Medical Officer
Signature
/s/ Dan Dearen, as Attorney-in-Fact for Karen Noblett
Issuer symbol
N/A
Transactions as of
18 Mar 2022
Net transactions value
-$774,359
Form type
4
Filing time
22 Mar 2022, 20:52:35 UTC
Previous filing
03 Feb 2022
Next filing
09 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXNX Common Stock Sale $774,359 -13,531 -24% $57.23 42,053 18 Mar 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $56.93 to $57.435. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.